X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (76431) 76431
Publication (6158) 6158
Book Review (962) 962
Book Chapter (431) 431
Book / eBook (181) 181
Newsletter (148) 148
Conference Proceeding (68) 68
Dissertation (60) 60
Newspaper Article (34) 34
Magazine Article (32) 32
Reference (7) 7
Data Set (6) 6
Trade Publication Article (4) 4
Presentation (3) 3
Paper (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (60486) 60486
index medicus (45837) 45837
female (40397) 40397
male (34685) 34685
middle aged (33668) 33668
oncology (31422) 31422
cancer (30131) 30131
aged (29826) 29826
adult (23390) 23390
prognosis (20832) 20832
carcinoma (18663) 18663
surgery (16452) 16452
aged, 80 and over (13870) 13870
survival (13509) 13509
tumors (12736) 12736
neoplasm staging (12254) 12254
analysis (12001) 12001
retrospective studies (11839) 11839
metastasis (11642) 11642
care and treatment (11454) 11454
chemotherapy (11249) 11249
research (10584) 10584
treatment outcome (10415) 10415
risk factors (9996) 9996
survival rate (9326) 9326
health aspects (9057) 9057
medicine & public health (8395) 8395
expression (7816) 7816
mortality (7489) 7489
survival analysis (7455) 7455
diagnosis (6862) 6862
animals (6852) 6852
follow-up studies (6831) 6831
medical prognosis (6459) 6459
immunohistochemistry (6317) 6317
patients (6314) 6314
lung cancer (6246) 6246
radiotherapy (6180) 6180
pathology (6087) 6087
disease-free survival (5991) 5991
squamous cell carcinoma (5944) 5944
development and progression (5850) 5850
lung neoplasms - pathology (5803) 5803
gastroenterology & hepatology (5780) 5780
gene expression (5760) 5760
genetic aspects (5717) 5717
hepatocellular carcinoma (5500) 5500
squamous-cell carcinoma (5469) 5469
lung neoplasms - mortality (5243) 5243
breast cancer (5090) 5090
adenocarcinoma (4940) 4940
kaplan-meier estimate (4912) 4912
liver cancer (4868) 4868
risk (4858) 4858
proteins (4831) 4831
apoptosis (4777) 4777
medicine (4770) 4770
studies (4765) 4765
carcinoma, squamous cell - pathology (4711) 4711
hepatocellular-carcinoma (4639) 4639
cancer therapies (4638) 4638
therapy (4558) 4558
multivariate analysis (4423) 4423
hematology, oncology and palliative medicine (4390) 4390
urology & nephrology (4366) 4366
colorectal cancer (4307) 4307
carcinoma, squamous cell - mortality (4255) 4255
cell line, tumor (4147) 4147
patient outcomes (4137) 4137
research article (4134) 4134
proportional hazards models (4120) 4120
biomarkers (4083) 4083
metastases (4059) 4059
article (4051) 4051
medical research (4049) 4049
oncology, experimental (4029) 4029
lymphatic metastasis (4024) 4024
combined modality therapy (3927) 3927
carcinoma, non-small-cell lung - pathology (3879) 3879
epidemiology (3876) 3876
carcinoma, non-small-cell lung - mortality (3847) 3847
lung cancer, non-small cell (3830) 3830
breast-cancer (3802) 3802
management (3789) 3789
time factors (3785) 3785
young adult (3775) 3775
respiratory system (3765) 3765
mice (3658) 3658
radiology, nuclear medicine & medical imaging (3623) 3623
recurrence (3623) 3623
abridged index medicus (3606) 3606
mutation (3532) 3532
antineoplastic combined chemotherapy protocols - therapeutic use (3408) 3408
multidisciplinary sciences (3375) 3375
gene expression regulation, neoplastic (3356) 3356
adolescent (3352) 3352
neoplasm invasiveness (3351) 3351
liver (3301) 3301
cell biology (3285) 3285
cancer research (3279) 3279
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (129) 129
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (11) 11
Collection Dvlpm't (Acquisitions) - Vendor file (10) 10
Robarts - Stacks (8) 8
Collection Dvlpm't (Acquisitions) - Closed Orders (7) 7
UTL at Downsview - May be requested (5) 5
Online Resources - Online (4) 4
UofT at Scarborough - Stacks (4) 4
Gerstein Science - Circulation Desk (3) 3
St. Michael's College (John M. Kelly) - 2nd Floor (3) 3
St. Michael's Hospital - Stacks (3) 3
UofT at Mississauga - Stacks (3) 3
Gerstein Science - Reference (2) 2
Humber River Regional Hospital - Finch Stacks (2) 2
Lakeridge Health Sciences - Oshawa (2) 2
Markham Stouffville Hospital - Stacks (2) 2
St Josephs Health Centre - Stacks (2) 2
Trinity College (John W Graham) - Stacks (2) 2
Baycrest Hospital - Stacks (1) 1
Credit Valley Hospital - Special Collections (1) 1
Humber River Regional Hospital - Church Stacks (1) 1
Knox College (Caven) - Stacks (1) 1
Markham Stouffville Hospital - Storage (1) 1
Mt Sinai Hospital - Pathology (1) 1
OISE - Stacks (1) 1
Providence Healthcare - Stacks (1) 1
Scarborough Hospital - Birchmount (1) 1
Scarborough Hospital - General (1) 1
Scarborough Hospital - Hospital Department (1) 1
Trillium Health Centre - Stacks (1) 1
Trinity College (John W Graham) - Storage (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
Victoria University Emmanuel College - Birge Storage (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (76783) 76783
German (128) 128
French (110) 110
Japanese (75) 75
Spanish (47) 47
Polish (37) 37
Chinese (21) 21
Russian (20) 20
Portuguese (12) 12
Italian (11) 11
Turkish (9) 9
Arabic (8) 8
Korean (6) 6
Hungarian (4) 4
Czech (3) 3
Norwegian (3) 3
Bulgarian (2) 2
Dutch (2) 2
Latvian (2) 2
Swedish (2) 2
Lithuanian (1) 1
Persian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 2, pp. 187 - 199
Summary Background We aimed to compare overall survival after standard-dose versus high-dose conformal radiotherapy with concurrent chemotherapy and the... 
Hematology, Oncology and Palliative Medicine | ONCOLOGY | COMPETING RISK | CLINICAL-TRIALS | THERAPY ONCOLOGY GROUP | CHEMORADIATION | INDUCTION | CARCINOMA | CHEMOTHERAPY | RADIATION-THERAPY | Prognosis | Follow-Up Studies | Lung Neoplasms - mortality | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Carcinoma, Large Cell - mortality | Radiotherapy, Image-Guided | Chemoradiotherapy | Carcinoma, Large Cell - secondary | Neoplasm Metastasis | Antibodies, Monoclonal, Humanized - administration & dosage | Carcinoma, Non-Small-Cell Lung - secondary | Carcinoma, Squamous Cell - mortality | Aged, 80 and over | Adult | Female | Cetuximab | Paclitaxel - administration & dosage | Radiotherapy Dosage | Carboplatin - administration & dosage | Carcinoma, Squamous Cell - therapy | Survival Rate | Combined Modality Therapy | Lung Neoplasms - therapy | Carcinoma, Non-Small-Cell Lung - mortality | Adenocarcinoma - secondary | Carcinoma, Non-Small-Cell Lung - therapy | Adenocarcinoma - therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Radiotherapy, Conformal | Carcinoma, Squamous Cell - secondary | Aged | Neoplasm Staging | Carcinoma, Large Cell - therapy | Adenocarcinoma - mortality | Antimitotic agents | Care and treatment | Chemotherapy | Dosage and administration | Lung cancer, Non-small cell | Antineoplastic agents | Radiotherapy | Cancer | Index Medicus
Journal Article
PLoS ONE, ISSN 1932-6203, 08/2015, Volume 10, Issue 8, p. e0136023
Background Immunotherapy can become a crucial therapeutic option to improve prognosis for lung cancer patients. First clinical trials with therapies targeting... 
CELL LUNG-CANCER | TUMOR-INFILTRATING LYMPHOCYTES | INTERLEUKIN-2 | GEFITINIB | IMPACT | MULTIDISCIPLINARY SCIENCES | ANTIBODY | B7-H1 | T-CELLS | CHEMOTHERAPY | LIGAND 1 EXPRESSION | Adenocarcinoma - pathology | Prognosis | Follow-Up Studies | Lung Neoplasms - mortality | Carcinoma, Large Cell - pathology | Carcinoma, Squamous Cell - metabolism | Carcinoma, Squamous Cell - pathology | Humans | Lung Neoplasms - metabolism | Lung Neoplasms - pathology | Male | Carcinoma, Large Cell - mortality | Immunoenzyme Techniques | Adenocarcinoma - metabolism | Carcinoma, Squamous Cell - mortality | Neoplasm Grading | Biomarkers, Tumor - metabolism | Female | Retrospective Studies | Carcinoma, Non-Small-Cell Lung - pathology | Carcinoma, Large Cell - metabolism | Carcinoma, Non-Small-Cell Lung - metabolism | Carcinoma, Squamous Cell - therapy | Programmed Cell Death 1 Receptor - metabolism | Survival Rate | Combined Modality Therapy | Lung Neoplasms - therapy | Carcinoma, Non-Small-Cell Lung - mortality | B7-H1 Antigen - metabolism | Carcinoma, Non-Small-Cell Lung - therapy | Adenocarcinoma - therapy | Aged | Neoplasm Staging | Carcinoma, Large Cell - therapy | Adenocarcinoma - mortality | Care and treatment | Physiological aspects | Genetic aspects | Research | Lung cancer, Non-small cell | Apoptosis | Immunohistochemistry | Thoracic surgery | PD-1 protein | Lung cancer | Clinical trials | Oncology | Cancer therapies | Lymph nodes | Subgroups | Proteins | Rank tests | Regression models | Bcl-x protein | Lymphocytes | Immunotherapy | Medical research | Immunoglobulins | Squamous cell carcinoma | Cell survival | Cytokines | Hematology | Tumor cells | Non-small cell lung carcinoma | Breast cancer | Regression analysis | Patients | Medicine | Pathology | Chemotherapy | Hospitals | Cell death | Medical prognosis | PD-L1 protein | Ligands | Diagnostic systems | Solid tumors | Lymph | Cancer | Tumors
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 10/2012, Volume 7, Issue 10, pp. 1547 - 1555
Journal Article
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 02/2012, Volume 7, Issue 2, pp. 340 - 347
Journal Article
Cancer, ISSN 0008-543X, 02/2012, Volume 118, Issue 3, pp. 729 - 739
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 04/2011, Volume 6, Issue 4, pp. 774 - 780
To explore whether the progression-free survival (PFS) with pemetrexed differs between anaplastic lymphoma kinase (ALK)-positive and other major molecular... 
KRAS | Anaplastic lymphoma kinase | Pemetrexed | Epidermal growth factor receptor | Non-small cell lung cancer | TARGET | NPM-ALK | PHASE-III | HISTOLOGY | DOCETAXEL | CHEMOTHERAPY | EML4-ALK | TRIAL | ONCOLOGY | RESPIRATORY SYSTEM | Carcinoma, Large Cell - drug therapy | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Prognosis | Follow-Up Studies | Guanine - analogs & derivatives | Lung Neoplasms - mortality | Carcinoma, Squamous Cell - genetics | Humans | Middle Aged | Male | Carcinoma, Large Cell - mortality | Organoplatinum Compounds - administration & dosage | Carcinoma, Squamous Cell - mortality | Polymerase Chain Reaction | Female | Adenocarcinoma - genetics | Carcinoma, Large Cell - genetics | Retrospective Studies | Lung Neoplasms - genetics | Carcinoma, Non-Small-Cell Lung - genetics | In Situ Hybridization, Fluorescence | Proto-Oncogene Proteins - genetics | Survival Rate | Mutation - genetics | Adenocarcinoma - drug therapy | Carcinoma, Non-Small-Cell Lung - mortality | Carcinoma, Squamous Cell - drug therapy | Receptor Protein-Tyrosine Kinases - genetics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Gene Rearrangement | Glutamates - administration & dosage | Carcinoma, Non-Small-Cell Lung - drug therapy | DNA, Neoplasm - genetics | Adenocarcinoma - mortality | Guanine - administration & dosage
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 07/2013, Volume 8, Issue 7, pp. 980 - 984
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 12/2012, Volume 7, Issue 12, pp. 1798 - 1806
Pathologic nodal stage is the key prognostic factor in resectable non–small-cell lung cancer (NSCLC). Mediastinal lymph node (MLN) metastasis connotes a poor... 
Outcome of care | Non–small-cell lung cancer | Surgical resection | Mediastinal lymph nodes | Staging | Quality of care | Non-small-cell lung cancer | FORTHCOMING 7TH EDITION | NUMBER | LONG-TERM SURVIVAL | TNM CLASSIFICATION | RANDOMIZED-TRIAL | SURGEON SPECIALTY | PULMONARY RESECTION | LYMPHADENECTOMY | ONCOLOGY | RESPIRATORY SYSTEM | OUTCOMES | Lymph Node Excision | Mediastinal Neoplasms - secondary | Adenocarcinoma - pathology | Prognosis | Follow-Up Studies | Adenocarcinoma, Bronchiolo-Alveolar - pathology | Lung Neoplasms - mortality | Carcinoma, Large Cell - pathology | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Adenocarcinoma, Bronchiolo-Alveolar - mortality | Carcinoma, Squamous Cell - surgery | Lung Neoplasms - pathology | Male | Mediastinal Neoplasms - mortality | Carcinoma, Large Cell - mortality | Pneumonectomy | Neoplasm Recurrence, Local - mortality | Neoplasm Recurrence, Local - surgery | Neoplasm Recurrence, Local - pathology | Carcinoma, Squamous Cell - mortality | Female | Mediastinal Neoplasms - surgery | Carcinoma, Non-Small-Cell Lung - pathology | SEER Program | Carcinoma, Non-Small-Cell Lung - surgery | Adenocarcinoma, Bronchiolo-Alveolar - surgery | Risk Factors | Survival Rate | Lymphatic Metastasis | Carcinoma, Non-Small-Cell Lung - mortality | Carcinoma, Large Cell - surgery | Lung Neoplasms - surgery | Aged | Neoplasm Staging | Adenocarcinoma - mortality | Adenocarcinoma - surgery | Cohort Studies
Journal Article
Cancer, ISSN 0008-543X, 10/2007, Volume 110, Issue 7, pp. 1532 - 1541
BACKGROUND. Platinum-based adjuvant chemotherapy in randomized trials has failed to provide a survival benefit in patients with resected stage I nonsmall cell... 
Histologic grade | Socioeconomic status | Mortality risk | Stage I nonsmall cell lung cancer | Epidemiology | Nonupper lobe tumor locations | Bronchioloalveolar carcinoma | ADJUVANT CHEMOTHERAPY | UNITED-STATES | LOCATION | NUMBER | LYMPH-NODES | RANDOMIZED-TRIAL | POLYMORPHISM | histologic grade | stage I nonsmall cell lung cancer | nonupper lobe tumor locations | epidemiology | CISPLATIN | ONCOLOGY | bronchioloalveolar carcinoma | socioeconomic status | ASSOCIATION | mortality risk | Lung Neoplasms - ethnology | Multivariate Analysis | Predictive Value of Tests | Adenocarcinoma - pathology | Prognosis | Adenocarcinoma, Bronchiolo-Alveolar - pathology | Asian Americans - statistics & numerical data | Lung Neoplasms - mortality | Carcinoma, Large Cell - pathology | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Adenocarcinoma, Bronchiolo-Alveolar - mortality | Lung Neoplasms - pathology | Male | Carcinoma, Large Cell - mortality | Carcinoma, Squamous Cell - mortality | Adult | Female | Registries | Carcinoma, Non-Small-Cell Lung - pathology | Carcinoma, Non-Small-Cell Lung - surgery | Risk Assessment | California - epidemiology | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Survival Rate | Carcinoma, Non-Small-Cell Lung - mortality | Pneumonectomy - methods | Lung Neoplasms - surgery | Aged | Carcinoma, Non-Small-Cell Lung - enzymology | Neoplasm Staging | Adenocarcinoma - mortality
Journal Article
Journal Article